Equity Overview
Price & Market Data
Price: $1.36
Daily Change: $0.00 / 0.00%
Daily Range: $1.28 - $1.43
Market Cap: $53,765,192
Daily Volume: 533,303
Performance Metrics
1 Week: -0.73%
1 Month: -7.48%
3 Months: -2.86%
6 Months: -32.00%
1 Year: -9.93%
YTD: -2.86%
Company Details
Employees: 5
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.